What You'll Learn
- Model drug pipeline development cycles and probability of technical success (PTS).
- Analyze payer-provider dynamics and insurance reimbursement pathways (Medicare/Medicaid).
- Evaluate market access strategies for novel therapies and medical devices.
Lesson Overview
Navigate the high-risk, high-return economics of blockbuster drug development pipelines, clinical trial probabilities, and payer reimbursement schemes.
Imagine your interviewer says: "Your client is a global biopharma company. They must decide whether to invest $800 million to fund Phase III trials for an Alzheimer's drug or spend $300 million to license a Phase II oncology therapy with a higher probability of success. How should they allocate their R&D budget?"
Why This Matters for Consulting Interviews
Life sciences cases test your ability to manage high risk and uncertainty (binary clinical trials) alongside complex pricing and regulatory friction.
Prerequisites
- Mergers & Acquisitions
- Chart Interpretation
Start This Lesson on PrepPartnr
← Back to preppartnr —
Start practicing with AI →